August 11, 2022
Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China
Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China Gaithersburg, MD (11 Aug. 2022) – BLA Regulatory LLC, a full-service biopharma regulatory consultancy, announced that its Founder, Dr. Li, will be presenting virtually at the 3rd Quality Science of Biologics Summit to be held between 12-13 Aug. 2022, Beijing, […]
Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China
Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China Gaithersburg, MD (11 Aug. 2022)...
As the project partner, BLA Regulatory congratulates ImmuneOnco for receiving Fast Track designation from the FDA to IMM2902 for the treatment of HER-2+ breast cancer patients
As the project partner, BLA Regulatory congratulates ImmuneOnco for receiving Fast Track designation from the FDA to IMM2902 for the...
As the regulatory consultant, Dr. Frank Li, congratulates BiOneCure Therapeutics on receiving US FDA IND may proceed letter for BIO-106
As the regulatory consultant, Dr. Frank Li, congratulates BiOneCure Therapeutics on receiving US FDA IND may proceed letter for BIO-106...